Precision Medicine for L/GCMN and Melanoma 2
Recruiting · NCT06605443 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fundacion Clinic per a la Recerca Biomédica
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Be over 18 years old
- Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC)
Exclusion criteria
- Not signing the informed consent form
- Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles
Where it is running
3 locations listed.
- Hospital Clínic de Barcelona (Dermatology service) - Barcelona, Spain
- Hospital Clínic Barcelona - Barcelona, Spain
- Hospital Clínic Barcelona - Barcelona, Spain